Axicabtagene ciloleucel (Yescarta)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Axicabtagene ciloleucel (Yescarta), covering 2025-11-28 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma [Phase 2]